Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Foghorn Therapeutics (FHTX) Other Operating Expenses (2024)

Historic Other Operating Expenses for Foghorn Therapeutics (FHTX) over the last 1 years, with Q2 2024 value amounting to $2.4 million.

  • Foghorn Therapeutics' Other Operating Expenses changed N/A to $2.4 million in Q2 2024 from the same period last year, while for Mar 2025 it was $2.4 million, marking a year-over-year change of. This contributed to the annual value of $2.4 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Foghorn Therapeutics reported Other Operating Expenses of $2.4 million as of Q2 2024.
  • In the past 5 years, Foghorn Therapeutics' Other Operating Expenses ranged from a high of $2.4 million in Q2 2024 and a low of $2.4 million during Q2 2024